Regeneron Pharmaceuticals, Inc. (LON:0R2M)
780.86
-5.88 (-0.75%)
At close: Nov 28, 2025
Regeneron Pharmaceuticals Employees
Regeneron Pharmaceuticals had 15,106 employees as of December 31, 2024. The number of employees increased by 1,656 or 12.31% compared to the previous year.
Employees
15,106
Change (1Y)
1,656
Growth (1Y)
12.31%
Revenue / Employee
696.33K GBP
Profits / Employee
223.74K GBP
Market Cap
60.47B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 15,106 | 1,656 | 12.31% |
| Dec 31, 2023 | 13,450 | 1,599 | 13.49% |
| Dec 31, 2022 | 11,851 | 1,483 | 14.30% |
| Dec 31, 2021 | 10,368 | 1,245 | 13.65% |
| Dec 31, 2020 | 9,123 | 1,023 | 12.63% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| Spire Healthcare Group | 15,703 |
| ConvaTec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| Genus | 3,190 |
Regeneron Pharmaceuticals News
- 9 days ago - Stocks making the biggest moves midday: Nvidia, Walmart, Strategy, Regeneron & more - CNBC
- 9 days ago - Regeneron Wins FDA Nod For Eylea HD With Reduced Injection Schedule For Patients With Vision Loss - Benzinga
- 9 days ago - Wells Fargo Raises Price Target for REGN to $700 | REGN Stock News - GuruFocus
- 9 days ago - Stocks to Watch Thursday: Walmart, Nvidia, Exact Sciences, Regeneron - The Wall Street Journal
- 9 days ago - Biggest stock movers Thursday: NVDA, PANW, and more - Seeking Alpha
- 9 days ago - FDA Approves Regeneron's EYLEA HD For Retinal Vein Occlusion And Monthly Dosing Across Indications - Nasdaq
- 10 days ago - Regeneron (REGN) Gains FDA Approval for Eylea HD Injection - GuruFocus
- 10 days ago - Regeneron gets FDA nod for Eylea in macular edema treatment - Seeking Alpha